SCHEMBL7913868

SCHEMBL7913868

CC(C)(C)OC(=O)N(N)c1ccc([N+](=O)[O-])cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.49
GAA P10253 3/20 0.42
CYP1A2 P05177 1/20 0.42
PKM P14618 1/20 0.41
MAPT P10636 6/20 0.41
RAB9A P51151 4/20 0.41
LMNA P02545 3/20 0.41
NPC1 O15118 3/20 0.41
ALDH1A1 P00352 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.40
ADRA2A P08913 2/20 0.40
ADRA2B P18089 2/20 0.40
ADRA2C P18825 2/20 0.40
SLC2A1 P11166 1/20 0.37
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6019396 0.86 CYP2C19 (0.51) CYP2C19GAACYP1A2PKMMAPT
SCHEMBL477465 0.85 CYP2C19 (0.50) CYP2C19GAACYP1A2PKMMAPT
SCHEMBL26626463 0.82 CYP2C19 (0.47) CYP2C19GAACYP1A2PKMMAPT
SCHEMBL26640360 0.79 PKM (0.46) CYP2C19GAACYP1A2PKMMAPT
SCHEMBL8723112 0.79 KDM4E (0.34) RAB9AALDH1A1POLBADRA2AADRA2B
SCHEMBL30182419 0.78 CYP2C19 (0.48) CYP2C19GAACYP1A2PKMMAPT
SCHEMBL2558802 0.77 HCAR3 (0.48) CYP2C19CYP1A2MAPTALDH1A1GABRA1
SCHEMBL28179558 0.75 CYP1A2 (0.46) CYP2C19GAACYP1A2PKMMAPT
SCHEMBL29973538 0.74 PKM (0.41) CYP2C19GAACYP1A2PKMMAPT
SCHEMBL19674261 0.74 ADRA2A (0.46) CYP2C19GAACYP1A2PKMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6217845-B1 IMAGING; THERAPY ANORMED, INC. (CA) 2001-04-17 US disclosed
US-5753520-A BIOCHEMICAL CONJUGATED WITH A HYDRAZINE OR A HYDRAZONE COMPOUND AS DRUG DELIVERY; HIGH BIOLOGICAL SPECIFICITY; MEDICINE FOR IMAGING, THERAPY, RADIOACTIVE TAGGING JOHNSON MATTHEY INC. (US) 1998-05-19 US disclosed
EP-0384769-B1 Protein labelling JOHNSON MATTHEY PLC (GB) 1996-04-24 EP disclosed
US-5420285-A Imaging for medicine JOHNSON MATTHEY, INC. (US) 1995-05-30 US disclosed
US-5206370-A Certain pyridyl hydrazines and hydrazides useful for protein labeling JOHNSON MATTHEY, INC. (US) 1993-04-27 US disclosed
EP-0384769-A2 Protein labelling JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 1990-08-29 EP disclosed